Our Ongoing Programs
Our programmes are more focused towards people affected by leprosy and persons with disabilities.
Our programmes are more focused towards people affected by leprosy and persons with disabilities.
The PEP++ study is a large international research project being implemented in India, Brazil, Bangladesh, and Nepal. It is a cluster-randomised controlled trial designed to test an enhanced preventive regimen for leprosy.
The Global Leprosy Mapping (GLM) Project is designed to modernize leprosy data systems in Nepal and strengthen evidence for targeted interventions. Reliable, case-based data and geospatial analysis are essential to support Nepal’s progress towards zero leprosy and to align with global leprosy targets.